trulieve cannabis - TCNNF

TCNNF

Close Chg Chg %
6.12 -0.13 -2.12%

Closed Market

5.99

-0.13 (2.12%)

Volume: 711.74K

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Company Overview: trulieve cannabis - TCNNF

TCNNF Key Data

Open

$6.15

Day Range

5.84 - 6.24

52 Week Range

4.75 - 14.50

Market Cap

$1.16B

Shares Outstanding

189.19M

Public Float

160.34M

Beta

1.59

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.75

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

931.04K

 

TCNNF Performance

1 Week
 
-11.91%
 
1 Month
 
-55.10%
 
3 Months
 
-37.60%
 
1 Year
 
7.35%
 
5 Years
 
-49.87%
 

TCNNF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About trulieve cannabis - TCNNF

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers on September 17, 1940 and is headquartered in Tallahassee, FL.

TCNNF At a Glance

Trulieve Cannabis Corp.
3494 Martin Hurst Road
Tallahassee, Florida 32312
Phone 1-850-480-7955 Revenue 1.13B
Industry Agricultural Commodities/Milling Net Income -526,796,000.00
Sector Process Industries Employees 5,400
Fiscal Year-end 12 / 2024
View SEC Filings

TCNNF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.869
Price to Book Ratio 0.684
Price to Cash Flow Ratio 4.864
Enterprise Value to EBITDA 4.614
Enterprise Value to Sales 1.06
Total Debt to Enterprise Value 0.359

TCNNF Efficiency

Revenue/Employee 209,109.815
Income Per Employee -97,554.815
Receivables Turnover 87.291
Total Asset Turnover 0.361

TCNNF Liquidity

Current Ratio 4.156
Quick Ratio 2.301
Cash Ratio 1.811

TCNNF Profitability

Gross Margin 42.402
Operating Margin 8.204
Pretax Margin -25.198
Net Margin -46.652
Return on Assets -13.752
Return on Equity -25.75
Return on Total Capital -23.362
Return on Invested Capital -20.478

TCNNF Capital Structure

Total Debt to Total Equity 30.354
Total Debt to Total Capital 23.286
Total Debt to Total Assets 15.473
Long-Term Debt to Equity 28.733
Long-Term Debt to Total Capital 22.042
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Trulieve Cannabis - TCNNF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
521.53M 938.39M 1.24B 1.13B
Sales Growth
+106.29% +79.93% +32.12% -8.92%
Cost of Goods Sold (COGS) incl D&A
147.72M 420.35M 677.19M 650.39M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
30.19M 78.22M 185.57M 166.85M
Depreciation
27.19M 48.42M 87.65M 86.45M
Amortization of Intangibles
3.00M 29.80M 97.92M 80.40M
COGS Growth
-36.66% +184.57% +61.10% -3.96%
Gross Income
373.82M 518.03M 562.62M 478.80M
Gross Income Growth
+1,806.99% +38.58% +8.61% -14.90%
Gross Profit Margin
+71.68% +55.20% +45.38% +42.40%
2020 2021 2022 2023 5-year trend
SG&A Expense
155.45M 315.72M 454.67M 386.16M
Research & Development
- - - -
-
Other SG&A
155.45M 315.72M 454.67M 386.16M
SGA Growth
+129.49% +103.10% +44.01% -15.07%
Other Operating Expense
- - - -
-
Unusual Expense
- 5.16M 72.90M 304.37M
EBIT after Unusual Expense
218.37M 197.15M 35.05M (211.72M)
Non Operating Income/Expense
(40.68M) 1.14M 1.38M 8.76M
Non-Operating Interest Income
- - 1.30M 6.16M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
20.24M 34.79M 79.77M 81.57M
Interest Expense Growth
+57.90% +71.90% +129.31% +2.25%
Gross Interest Expense
20.24M 34.79M 84.47M 81.72M
Interest Capitalized
- - 4.70M 148.00K
-
Pretax Income
157.45M 163.51M (43.35M) (284.54M)
Pretax Income Growth
-42.21% +3.85% -126.51% -556.45%
Pretax Margin
+30.19% +17.42% -3.50% -25.20%
Income Tax
94.45M 146.06M 161.82M 151.36M
Income Tax - Current - Domestic
99.34M 172.32M 228.68M 171.49M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(4.89M) (26.26M) (18.35M) (18.94M)
Income Tax - Deferred - Foreign
- - (48.51M) (1.19M)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
63.00M 17.45M (205.17M) (435.90M)
Minority Interest Expense
- (587.00K) (6.66M) (5.15M)
Net Income
63.00M 18.03M (198.50M) (430.75M)
Net Income Growth
-64.61% -71.38% -1,200.83% -117.00%
Net Margin Growth
+12.08% +1.92% -16.01% -38.15%
Extraordinaries & Discontinued Operations
- - (47.56M) (96.05M)
-
Discontinued Operations
- - (47.56M) (96.05M)
-
Net Income After Extraordinaries
63.00M 18.03M (246.06M) (526.80M)
Preferred Dividends
- - - -
-
Net Income Available to Common
63.00M 18.03M (246.06M) (526.80M)
EPS (Basic)
0.5547 0.1294 -1.3089 -2.7877
EPS (Basic) Growth
-65.66% -76.67% -1,111.51% -112.98%
Basic Shares Outstanding
113.57M 139.37M 188.00M 188.97M
EPS (Diluted)
0.5324 0.1229 -1.3089 -2.7877
EPS (Diluted) Growth
-65.51% -76.92% -1,165.01% -112.98%
Diluted Shares Outstanding
118.33M 146.76M 188.00M 188.97M
EBITDA
248.55M 280.54M 293.52M 259.49M
EBITDA Growth
+904.61% +12.87% +4.63% -11.59%
EBITDA Margin
+47.66% +29.90% +23.67% +22.98%

Snapshot

Average Recommendation BUY Average Target Price 18.319
Number of Ratings 10 Current Quarters Estimate -0.22
FY Report Date 12 / 2024 Current Year's Estimate -0.673
Last Quarter’s Earnings -0.32 Median PE on CY Estimate N/A
Year Ago Earnings -2.79 Next Fiscal Year Estimate -0.274
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 4 9 9
Mean Estimate -0.22 -0.07 -0.67 -0.27
High Estimates -0.07 -0.04 -0.26 -0.01
Low Estimate -0.41 -0.11 -0.93 -0.61
Coefficient of Variance -69.26 -41.70 -33.07 -63.69

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 10 11
OVERWEIGHT 0 1 1
HOLD 2 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Trulieve Cannabis in the News